Pieter Wesseling Selected Research

Ligands

1/2020	Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin.
6/2019	Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma.
1/2018	Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8.
8/2010	Prognostic significance and mechanism of Treg infiltration in human brain tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pieter Wesseling Research Topics

Disease

89	Neoplasms (Cancer) 01/2022 - 07/2003
60	Glioma (Gliomas) 01/2022 - 11/2004
32	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 11/2006
15	Brain Neoplasms (Brain Tumor) 11/2021 - 07/2003
10	Neoplasm Metastasis (Metastasis) 10/2020 - 01/2002
7	Diffuse Intrinsic Pontine Glioma 01/2018 - 07/2011
5	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 01/2016
5	Breast Neoplasms (Breast Cancer) 11/2014 - 01/2010
4	Oligodendroglioma 01/2020 - 03/2010
4	Hypoxia (Hypoxemia) 05/2017 - 02/2004
4	Melanoma (Melanoma, Malignant) 03/2010 - 09/2003
4	Amyloid Plaque 10/2004 - 07/2002
4	Alzheimer Disease (Alzheimer's Disease) 10/2004 - 07/2002
3	Medulloblastoma 01/2022 - 01/2018
3	Neurilemmoma (Schwannoma) 09/2014 - 04/2007
2	Ependymoma 01/2022 - 11/2003
2	Rhabdoid Tumor (Rhabdoid Tumors) 10/2021 - 09/2014
2	Multiple Sclerosis 10/2020 - 06/2005
2	Necrosis 01/2019 - 06/2012
2	Uveal melanoma 06/2015 - 04/2015
2	Keratitis 06/2005 - 05/2003
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2005 - 10/2002
1	Central Nervous System Neoplasms 01/2022
1	Germinoma 01/2022
1	Residual Neoplasm 12/2021
1	Pleomorphic Adenoma 11/2021
1	Turcot syndrome 01/2021
1	Vomiting 01/2021
1	Nausea 01/2021
1	Meningioma (Meningiomas) 01/2021

Drug/Important Bio-Agent (IBA)

16	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 10/2007
16	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2005
12	Pharmaceutical PreparationsIBA 12/2021 - 01/2013
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2006
9	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2010
8	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 07/2011
6	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2015
6	dipinacoline glutamateIBA 05/2017 - 07/2011
6	Vincristine (Oncovin)FDA LinkGeneric 03/2016 - 12/2009
6	Procarbazine (Matulane)FDA Link 03/2016 - 12/2009
5	ParaffinIBA 06/2021 - 10/2009
5	Biological ProductsIBA 01/2021 - 10/2009
5	Lomustine (CCNU)FDA Link 03/2016 - 12/2009
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2004
4	tetraethylpyrazine (TEP)IBA 10/2020 - 11/2015
4	LigandsIBA 01/2020 - 08/2010
4	Alkylating AgentsIBA 12/2019 - 10/2007
4	Formaldehyde (Formol)FDA Link 06/2015 - 10/2009
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2013 - 09/2004
4	vandetanib (ZD6474)IBA 06/2012 - 09/2004
3	MethyltransferasesIBA 01/2021 - 07/2011
3	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 07/2018
3	GadoliniumIBA 01/2020 - 01/2012
3	Bevacizumab (Avastin)FDA Link 01/2018 - 12/2013
3	Peptides (Polypeptides)IBA 01/2018 - 02/2004
3	cabozantinibIBA 11/2017 - 01/2013
3	Phosphotransferases (Kinase)IBA 11/2017 - 03/2010
3	NADP (NADPH)IBA 01/2016 - 05/2013
3	Protein Tyrosine PhosphatasesIBA 01/2016 - 02/2010
3	Messenger RNA (mRNA)IBA 01/2016 - 06/2014
3	Tyrosine Kinase InhibitorsIBA 12/2013 - 09/2004
3	Contrast MediaIBA 01/2012 - 07/2003
3	Codon (Codons)IBA 12/2010 - 03/2008
3	Amyloid (Amyloid Fibrils)IBA 01/2005 - 10/2002
3	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 10/2004 - 07/2002
2	epidermal growth factor receptor VIIIIBA 01/2021 - 10/2009
2	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2020 - 01/2018
2	alpha-hydroxyglutarateIBA 10/2020 - 05/2013
2	NucleotidesIBA 12/2019 - 01/2018
2	89Zr-bevacizumabIBA 01/2018 - 01/2016
2	Chemokine ReceptorsIBA 01/2018 - 08/2010
2	Complement System Proteins (Complement)IBA 01/2018 - 09/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2017 - 02/2010
2	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2016 - 02/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2012 - 01/2010
2	Growth Factor ReceptorsIBA 02/2010 - 08/2007
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 05/2008 - 07/2003
2	Gadolinium DTPA (Magnevist)FDA Link 05/2008 - 07/2003
2	ferric oxide (iron oxide)IBA 05/2008 - 07/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2007 - 02/2004
2	Monoclonal AntibodiesIBA 07/2007 - 02/2004
2	Protein Isoforms (Isoforms)IBA 11/2006 - 09/2003
2	Voriconazole (Vfend)FDA LinkGeneric 06/2005 - 05/2003
2	Amyloid beta-PeptidesIBA 10/2004 - 07/2002
1	68Ga-pentixaforIBA 01/2022
1	Reticulin (Reticular Fiber)IBA 01/2022
1	Retroelements (Retrotransposon)IBA 10/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	isocitrate dehydrogenase (NADP+)IBA 01/2021

Therapy/Procedure

25	Therapeutics 01/2022 - 07/2003
18	Drug Therapy (Chemotherapy) 01/2022 - 10/2007
17	Radiotherapy 01/2022 - 11/2003
10	Ligation 06/2015 - 10/2005
7	Immunotherapy 01/2020 - 07/2007
4	Aftercare (After-Treatment) 01/2021 - 09/2004
1	Chemoradiotherapy 01/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Conformal Radiotherapy 01/2021